Name
CLINICAL PARALLEL 9 - Remaining Challenges in Hepatitis C
Date & Time
Thursday, March 20, 2025, 3:30 PM - 5:30 PM
Speakers
Jennifer Price, University of California, San Francisco
Norah Terrault, Keck School of Medicine of USC
Jason Grebely, The Kirby Institute, UNSW
Astha Kanani, National Clinician Consultation Center
Jordan Feld, University Health Network / Toronto Centre for Liver Disease
Norah Terrault, Keck School of Medicine of USC
Jason Grebely, The Kirby Institute, UNSW
Astha Kanani, National Clinician Consultation Center
Jordan Feld, University Health Network / Toronto Centre for Liver Disease
Description
- HCV : Improving care after HCV diagnosis and after HCV Cure Jennifer Price
- Treatment of HCV in Context of HCC - Remaining Challenges in 2025 Norah Terrault
- Oral Presentation: A NATIONAL PROGRAM TO SCALE-UP POINT-OF-CARE TESTING AND TREATMENT FOR HEPATITIS C INFECTION IN AUSTRALIA, 2022-2024 Jason Grebely
- Oral Presentation: HOW MUCH DAA TREATMENT IS ENOUGH? OUTCOMES FROM A LARGE CASE SERIES OF HCV TREATMENT INTERRUPTIONS Astha Kanani
- Oral Presentation: ADHERENCE AND DOSE INTERRUPTIONS OF GLECAPREVIR/PIBRENTASVIR IN CHRONIC HCV PATIENTS WITH MULTIPLE COMORBIDITIES AND ON CONCOMITANT MEDICATIONS Jordan Feld
- Q&A